Survival Outcome after Stereotactic Body Radiation Therapy and Surgery for Early Stage Non-Small Cell Lung Cancer: A Meta-Analysis

REFERENCES

• Morgensztern D, Ng SH, Gao F, Govindan R. Trends in stage distribution for patients with non-small cell lung cancer: A National Cancer Database survey. J Thorac Oncol: Off Publ Int Assoc Study Lung Cancer 2010;5(1):29–33.
   Google Scholar
• Shirvani SM, Jiang J, Chang JY, Welsh JW, Gomez DR, Swisher S, et al. Comparative effectiveness of 5 treatment strategies for early-stage non-small cell lung cancer in the elderly. Int J Radiat Oncol, Biol, Phys. 2012;84(5):1060–1070.
   PubMed Web of Science ®Google Scholar
• Wood DE. National comprehensive cancer network (NCCN) clinical practice guidelines for lung cancer screening. Thorac Surg Clin. 2015;25(2):185–197.
   PubMed Web of Science ®Google Scholar
• Timmerman R, Paulus R, Galvin J, Michalski J, Straube W, Bradley J, et al. Stereotactic body radiation therapy for inoperable early stage lung cancer. Jama 2010;303(11):1070–1076.
   PubMed Web of Science ®Google Scholar
• Haasbeek CJ, Palma D, Visser O, Lagerwaard FJ, Slotman B, Senan S. Early-stage lung cancer in elderly patients: a population-based study of changes in treatment patterns and survival in the Netherlands. Ann Oncol: Off J Eur Soc Med Oncol. 2012;23(10):2743–2747.
   PubMed Web of Science ®Google Scholar
• Onishi H, Araki T, Shirato H, Nagata Y, Hiraoka M, Gomi K, et al. Stereotactic hypofractionated high-dose irradiation for stage I nonsmall cell lung carcinoma: clinical outcomes in 245 subjects in a Japanese multiinstitutional study. Cancer 2004;101(7):1623–1631.
   PubMed Web of Science ®Google Scholar
• Olsen JR, Robinson CG, El Naqa I, Creach KM, Drzymala RE, Bloch C, et al. Dose-response for stereotactic body radiotherapy in early-stage non-small-cell lung cancer. Int J Radiat Oncol, Biol, Phys. 2011;81(4):e299–303.
   PubMed Web of Science ®Google Scholar
• Hamaji M, Chen F, Matsuo Y, Kawaguchi A, Morita S, Ueki N, et al. Video-assisted thoracoscopic lobectomy versus stereotactic radiotherapy for stage I lung cancer. Ann Thorac Surg. 2015;99(4):1122–1129.
   PubMed Web of Science ®Google Scholar
• Puri V, Crabtree TD, Kymes S, Gregory M, Bell J, Bradley JD, et al. A comparison of surgical intervention and stereotactic body radiation therapy for stage I lung cancer in high-risk patients: a decision analysis. J Thorac Cardiovasc Surg. 2012;143(2):428–436.
   PubMed Web of Science ®Google Scholar
• Robinson CG, DeWees TA, El Naqa IM, Creach KM, Olsen JR, Crabtree TD, et al. Patterns of failure after stereotactic body radiation therapy or lobar resection for clinical stage I non-small-cell lung cancer. J Thorac Oncol: Off Publ Int Assoc Study Lung Cancer 2013;8(2):192–201.
   Google Scholar
• Palma D, Visser O, Lagerwaard FJ, Belderbos J, Slotman B, Senan S. Treatment of stage I NSCLC in elderly patients: a population-based matched-pair comparison of stereotactic radiotherapy versus surgery. Radiother Oncol: J Eur Soc Ther Radiol Oncol. 2011;101(2):240–244.
   PubMed Web of Science ®Google Scholar
• Varlotto J, Fakiris A, Flickinger J, Medford-Davis L, Liss A, Shelkey J, et al. Matched-pair and propensity score comparisons of outcomes of patients with clinical stage I non-small cell lung cancer treated with resection or stereotactic radiosurgery. Cancer 2013;119(15):2683–2691.
   PubMed Web of Science ®Google Scholar
• Matsuo Y, Chen F, Hamaji M, Kawaguchi A, Ueki N, Nagata Y, et al. Comparison of long-term survival outcomes between stereotactic body radiotherapy and sublobar resection for stage I non-small-cell lung cancer in patients at high risk for lobectomy: A propensity score matching analysis. Eur J Cancer 2014;50(17):2932–2938.
   PubMed Web of Science ®Google Scholar
• Port JL, Parashar B, Osakwe N, Nasar A, Lee PC, Paul S, et al. A propensity-matched analysis of wedge resection and stereotactic body radiotherapy for early stage lung cancer. Ann Thorac Surg. 2014;98(4):1152–1159.
   PubMed Web of Science ®Google Scholar
• Nakagawa T, Negoro Y, Matsuoka T, Okumura N, Dodo Y. Comparison of the outcomes of stereotactic body radiotherapy and surgery in elderly patients with cT1-2N0M0 non-small cell lung cancer. Respir Invest. 2014;52(4):221–226.
   PubMedGoogle Scholar
• van den Berg LL, Klinkenberg TJ, Groen HJ, Widder J. Patterns of Recurrence and Survival after Surgery or Stereotactic Radiotherapy for Early Stage NSCLC. J Thorac Oncol: Off Publ Int Assoc Study Lung Cancer 2015;10(5):826–831.
   Google Scholar
• Tierney JF, Stewart LA, Ghersi D, Burdett S, Sydes MR. Practical methods for incorporating summary time-to-event data into meta-analysis. Trials 2007;8:16.
   PubMed Web of Science ®Google Scholar
• Verstegen NE, Oosterhuis JW, Palma DA, Rodrigues G, Lagerwaard FJ, van der Elst A, et al. Stage I-II non-small-cell lung cancer treated using either stereotactic ablative radiotherapy (SABR) or lobectomy by video-assisted thoracoscopic surgery (VATS): outcomes of a propensity score-matched analysis. Ann Oncol: Off J Eur Soc Med Oncol. 2013;24(6):1543–1548.
   PubMed Web of Science ®Google Scholar
• Kastelijn EA, El Sharouni SY, Hofman FN, Van Putte BP, Monninkhof EM, Van Vulpen M, et al. Clinical outcomes in Early-stage NSCLC treated with stereotactic body radiotherapy versus surgical resection. Anticancer Res. 2015;35(10):5607–5614.
   PubMed Web of Science ®Google Scholar
• Crabtree TD, Puri V, Robinson C, Bradley J, Broderick S, Patterson GA, et al. Analysis of first recurrence and survival in patients with stage I non-small cell lung cancer treated with surgical resection or stereotactic radiation therapy. J Thorac Cardiovasc Surg. 2014;147(4):1183–1191; discussion 91-2.
   PubMed Web of Science ®Google Scholar
• Allen MS, Darling GE, Pechet TT, Mitchell JD, Herndon JE, 2nd, Landreneau RJ, et al. Morbidity and mortality of major pulmonary resections in patients with early-stage lung cancer: Initial results of the randomized, prospective ACOSOG Z0030 trial. Ann Thorac Surg. 2006;81(3):1013–1019; discussion 9-20.
   PubMed Web of Science ®Google Scholar
• Ilonen IK, Rasanen JV, Knuuttila A, Salo JA, Sihvo EI. Anatomic thoracoscopic lung resection for non-small cell lung cancer in stage I is associated with less morbidity and shorter hospitalization than thoracotomy. Acta Oncol. 2011;50(7):1126–1132.
   PubMed Web of Science ®Google Scholar
• Smith CB, Kale M, Mhango G, Neugut AI, Hershman DL, Mandeli JP, et al. Comparative outcomes of elderly stage I lung cancer patients treated with segmentectomy via video-assisted thoracoscopic surgery versus open resection. J Thorac Oncol: Off Publ Int Assoc Study Lung Cancer 2014;9(3):383–389.
   Google Scholar
• Senan S, Paul MA, Lagerwaard FJ. Treatment of early-stage lung cancer detected by screening: surgery or stereotactic ablative radiotherapy? Lancet Oncol. 2013;14(7):e270–274.
   PubMed Web of Science ®Google Scholar
• Senan S, Gundy C, Haasbeek CJ, Slotman BJ, Aaronson NK, Lagerwaard FJ. Health-related quality of life (HRQOL) after stereotactic body radiotherapy (SBRT) for stage I non-small cell lung cancer (NSCLC). J Clin Oncol. 2010;28(15_suppl):7079.
   Web of Science ®Google Scholar
• Schulte T, Schniewind B, Walter J, Dohrmann P, Kuchler T, Kurdow R. Age-related impairment of quality of life after lung resection for non-small cell lung cancer. Lung Cancer 2010;68(1):115–120.
   PubMed Web of Science ®Google Scholar
• Palma D, Lagerwaard F, Rodrigues G, Haasbeek C, Senan S. Curative treatment of Stage I non-small-cell lung cancer in patients with severe COPD: stereotactic radiotherapy outcomes and systematic review. Int J Radiat Oncol, Biol, Phys. 2012;82(3):1149–1156.
   PubMed Web of Science ®Google Scholar
• Parashar B, Singh P, Christos P, Arora S, Desai P, Wernicke AG, et al. Stereotactic body radiation therapy (SBRT) for early stage lung cancer delivers clinically significant radiation to the draining lymph nodes. J Radiosurgery SBRT. 2013;2(4):339–340.
   PubMedGoogle Scholar
• Reese AS, Feigenberg SJ, Husain A, Webb TJ, Hausner PF, Edelman MJ, et al. Stereotactic Ablative Radiotherapy (SABR): Impact on the Immune System and Potential for Future Therapeutic Modulation. Mol Cell Pharmacol. 2013;5(1):19–25.
   PubMedGoogle Scholar
• Chang JY, Senan S, Paul MA, Mehran RJ, Louie AV, Balter P, et al. Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: A pooled analysis of two randomised trials. Lancet Oncol. 2015;16(6):630–637.
   PubMed Web of Science ®Google Scholar